Frequency of high-risk hormone receptor-positive breast cancer patients was much higher in Japanese breast cancer patients with germline BRCA1/2 mutations than in sporadic breast cancer patients

Breast J. 2021 Feb;27(2):188-190. doi: 10.1111/tbj.14150. Epub 2020 Dec 30.

Yoshimi Ide^{1

2}, Lei Liu³, Sakiko Miura⁴, Mayuko Inuzuka¹, Sadako Akashi-Tanaka¹, Terumasa Sawada^{1

5}, Seigo Nakamura^{1

3}

¹ Division of Breast Oncology, Showa University Hospital, Tokyo, Japan.
² Division of Breast Oncology, Kikuna Memorial Hospital, Yokohama, Japan.
³ The Third Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Centre, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre of Cancer, Tianjin, China.
⁴ Department of Pathology, Showa University Hospital, Tokyo, Japan.
⁵ NTT Medical Centre, Department of Breast Surgical Oncology, Tokyo, Japan.

No abstract available

Publication types